25 of the Best Oncologists Near Me

Deepa Rangachari is an Internal Medicine specialist and an Oncologist practicing medicine in Boston, Massachusetts. Dr. Rangachari is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Lung Cancer, EGFR Positive Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Thymectomy. Dr. Rangachari is board certified in American Board Of Internal Medicine.

Dr. William H. Sharfman is an associate professor of oncology and dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include cutaneous oncology, dermatology and immunotherapy. He helped create the well-established Melanoma Program at the Johns Hopkins Kimmel Cancer Center in 1994. Dr. Sharfman serves as the director of cutaneous oncology and clinical co-director for oncology at the Johns Hopkins Melanoma Program. He earned his M.D. from the University of Toledo College of Medicine. He completed his residency at Cleveland Clinic and performed a fellowship in hematology and oncology at Cleveland Clinic. Dr. Sharfman's research interests include novel therapies for high risk and advanced melanoma patients. Dr. Sharfman is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Eccrine Porocarcinoma, and Pancreatic Cancer. Dr. Sharfman is board certified in American Board Of Internal Medicine.

My research interests include: CSF-1 and its role in neoplastic progression and metastasis of ovarian cancer; the role of RNA binding proteins and miRNAs in regulation of CSF-1 expression. Androgens and neoplastic transformation of normal ovarian surface epithelium. and the c-fms proto-oncogene and breast cancer invasiveness and bone metastasis; mechanism of regulation of c-fms expression novel c-fms RNA binding proteins and miRNAs. Dr. Chambers is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Oophorectomy, and Salpingo-Oophorectomy. Dr. Chambers is board certified in American Board Of Obstetrics & Gynecology and American Board Of Obstetrics & Gynecology-Gynecologic Oncology. Dr. Chambers is currently accepting new patients.

Carol Karp is an Oncologist practicing medicine in Miami, Florida. Dr. Karp is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Pterygium, Pinguecula, Melanoma of the Eye, Corneal Transplant, and Trabeculectomy. Dr. Karp is currently accepting new patients.

Dr. Daniel Hamstra specializes in prostate cancer and tumors of the brain and spine with a particular focus on understanding patients’ experience both during and after treatment. He is the William T. Butler Professor and Chair of Radiation Oncology at Baylor College of Medicine.Dr. Hamstra has led local and national clinical trials of radiation therapy in prostate cancer. His work has made a substantial impact on the growing understanding and appreciation of patient-reported quality of life after radiation therapy.Dr. Hamstra received a B.A. in Biochemistry from Calvin College in Grand Rapids, Michigan and his medical degree and Ph.D. in Pharmacology from The University of Michigan - Ann Arbor, where he also completed an internship in internal medicine and residency in radiation oncology. Dr. Hamstra is a Diplomat of the American Board of Radiology in Radiation Oncology. He is a member of the American Society of Clinical Oncology, the American Society of Therapeutic Radiation Oncology and the Radiological Society of North America. Dr. Hamstra is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Pleuropulmonary Blastoma, Posterior Fossa Tumor, Familial Prostate Cancer, and Prostatectomy. Dr. Hamstra is currently accepting new patients.

Luis A. Rojas, MD, provides gynecologic oncology services at Avera Medical Group Gynecologic Oncology in Sioux Falls, SD. Dr. Rojas is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Malignant Mixed Mullerian Tumor, Virilizing Ovarian Tumor, Hysterectomy, and Oophorectomy. Dr. Rojas is board certified in American Board Of Obstetrics And Gynecology; Board Certified In Gynecologic Oncology.

Dr. Noah Hahn is a medical oncologist in the Baltimore area, caring for patients with bladder cancer. He serves as the deputy director of the Greenberg Bladder Cancer Institute at the Johns Hopkins School of Medicine. Dr. Hahn earned his M.D. from Indiana University School of Medicine. He completed his residency in internal medicine at Duke University School of Medicine and performed a fellowship in medical oncology at Indiana University School of Medicine. Dr. Hahn joined the Johns Hopkins faculty in 2014. Prior to joining Johns Hopkins, Dr. Hahn was the director of the Genitourinary Medical Oncology Program at Indiana University and chief scientific officer for the Hoosier Oncology Group, a cancer research organization that evaluates innovative and promising approaches to cancer treatment. He is currently conducting clinical trials to test new therapies for bladder cancer, including those for early stage bladder cancer. Dr. Hahn is a member of the Bladder Cancer Task Force for the National Cancer Institute’s Genitourinary Cancer Steering Committee and is chair of the Bladder Cancer Subcommittee of the Eastern Cooperative Oncology Group. Dr. Hahn is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Upper Tract Urothelial Carcinoma (UTUC), and Nephrectomy.

Christine L Hann, completed her MD and Ph.D. at Jefferson Medical College/Thomas Jefferson University follwed by an internal medicine residency at the University of Chicago Hospitals. Following a fellowship at Johns Hopkins University in Hematology and Oncology, Dr. Hann joined the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center as a member of the Upper Aerodigestive Cancer Program and sees patients with non-small cell and small cell lung cancer. Dr. Hann's research focus is on developing novel therapeutics for lung cancer, particularly small cell lung cancer (SCLC) and neuroendocrine tumors (NETs) such as carcinoid tumors of the lung. As a faculty member she is involved in both clinical and laboratory research. Specific research projects include: 1) Studying mechanisms of resistant to small molecule inhibitors of the antiapoptotic protein, BCL-2 using patient-derived xenograft models. Her preclinical work has led to an NCI-sponsored Phase 1/2 clinical trial combining a BCL-2 inhibitor with a TORC1/2 inhibitors which is currently underway (NCT03366103). 2) Preclinical evaluation of various therapeutics including epigenetic modulators (LSD1 inhibitors) and nanoliposome chemotherapy in SCLC PDXs; 3) Modeling and characterizing chemoradiotherapy resistance in preclinical models of SCLC. She, along with Dr. Luigi Marchionni in Biostatistics and Dr. Phuoc Tran in the Department of Radiation Oncology, were recently awarded a 5-year NCI-sponsored U01 grant to study mechanisms of chemoradiation resistance in SCLC. Dr. Hann is PI of several trials in SCLC and NSCLC and is leading investigator-initiated clinical trials in SCLC and NETs. Dr. Hann is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Squamous Cell Lung Carcinoma. Dr. Hann is board certified in American Board Of Internal Medicine.

David Mcdermott is an Internal Medicine specialist and an Oncologist practicing medicine in Boston, Massachusetts. Dr. Mcdermott is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Melanoma, Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, and Nephrectomy. Dr. Mcdermott is board certified in American Board Of Internal Medicine.

Aziz Nazha is a Hematologist and a Hematologist Oncology provider practicing medicine in Cherry Hill, New Jersey. Dr. Nazha is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Nazha is board certified in Medical Oncology and Hematology/Oncology. Dr. Nazha is currently accepting new patients.

Dr. Owen A. O'Connor is internationally renowned for his expertise on the diagnosis and treatment of all forms of lymphoma, with over 25 years of experience in academic medicine. He has invented and pioneered the development of several first in class drugs for the treatment of lymphoma, including one he co-invented for T-cell lymphoma which has now been approved in over 35 countries around the world. He has held several prestigious leadership positions at the major cancer centers in New York City, including Memorial Sloan Kettering Cancer Center, New York University Medical Center, and Cornell and Columbia University Medical Centers. Dr. O'connor is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Non-Hodgkin Lymphoma, and Anaplastic Large Cell Lymphoma.

Alexander Olawaiye, MD, is a professor of gynecologic oncology at the University of Pittsburgh and Magee-Womens Hospital of UPMC. He specializes in gynecologic malignancies, as well as endometrial, ovarian, cervical, vulvar, and vaginal cancers.Dr. Olawaiye is board-certified in obstetrics and gynecology as well as gynecologic oncology. He completed an undergraduate degree at the University of Ibadan, Nigeria, and received a medical degree from the Royal College of Obstetricians and Gynecologists in London, UK. Dr. Olawaiye completed a residency at the State University of New York at Buffalo, and a gynecologic oncology fellowship at Harvard Medical School.Dr. Olawaiye is a member of professional organizations such as the Society for Gynecologic Oncologists, American Society of Gynecologic Oncologists and the American Joint Committee on Cancer. He maintains a research interest in translational and clinical research for endometrial, ovarian, cervical, and vulvar cancers. Dr. Olawaiye is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Cervical Cancer, Hysterectomy, and Vulvectomy. Dr. Olawaiye is board certified in American Board Of Obstetrics And Gynecology and American Board Of Obstetrics And Gynecology. Dr. Olawaiye is currently accepting new patients.

I specialize in the treatment of gastrointestinal (GI) cancers with a focus on clinical trials. Clinical trial patients can come to me at any point during their disease, but they usually come to me looking for an alternative therapy once standard treatments have not been effective. I decided to become a doctor later in my career. I originally graduated from university with a non-science degree, but the excitement of advancing medical breakthroughs inspired me to start a career in medicine. As a Duke physician, I enjoy the diverse experiences that I get to have each week. In addition to taking care of patients and conducting research, I work closely with other doctors on crafting treatment plans. I also find it fulfilling to be able to apply my research to patient care. In my spare time, I enjoy spending time with my family, jogging and skiing. Dr. Strickler is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Pancreatic Cancer, Ampullary Cancer, and Familial Colorectal Cancer. Dr. Strickler is board certified in American Board Of Internal Med, Internal Medicine and American Board Of Internal Med, Medical Oncology.

Ana De Jesus is an Oncologist practicing medicine in Baltimore, Maryland. Dr. De Jesus is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreaticoduodenectomy, and Pancreatectomy. Dr. De Jesus is board certified in American Board Of Internal Medicine.

Michelle Boisen, MD, specializes in gynecologic oncology and is certified in obstetrics and gynecology and gynecologic oncology by the American Board of Obstetrics and Gynecology. She practices at University of Pittsburgh Physicians, Department of Women's Health and is affiliated with UPMC Shadyside, UPMC Mercy, UPMC Passavant, UPMC Magee-Womens Hospital, UPMC Altoona, and UPMC Presbyterian. She completed her residency at University of Pittsburgh School of Medicine and her medical degree at University of Wisconsin School of Medicine. Dr. Boisen is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Vulvar Cancer, Hysterectomy, and Vulvectomy. Dr. Boisen is board certified in American Board Of Obstetrics And Gynecology and American Board Of Obstetrics And Gynecology. Dr. Boisen is currently accepting new patients.

Peter Silberstein is a Hematologist and an Oncologist practicing medicine in Omaha, Nebraska. Dr. Silberstein is highly rated in 115 conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Hodgkin Lymphoma, Clear Cell Sarcoma, Thyroidectomy, and Prostatectomy. Dr. Silberstein is board certified in Hematology - American Board Of Internal Medicine, Internal Medicine - American Board Of Internal Medicine, and Medical Oncology - American Board Of Internal Medicine. Dr. Silberstein is currently accepting new patients.

Cara Bondly is a Hematologist practicing medicine in Birmingham, Alabama. Dr. Bondly is highly rated in 265 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Childhood Iron Deficiency Anemia, Angiosarcoma, and Bone Marrow Aspiration.

Prasad Kudalkar is a Hematologist Oncology specialist and an Oncologist practicing medicine in Fairfield, Ohio. Dr. Kudalkar is highly rated in 115 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Lymphofollicular Hyperplasia. Dr. Kudalkar is board certified in American Board Of Internal Medicine. Dr. Kudalkar is currently accepting new patients.

Kerry Rodabaugh is an Oncologist practicing medicine in Omaha, Nebraska. She has been practicing medicine for over 36 years. Dr. Rodabaugh is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Malignant Mixed Mullerian Tumor, Endometrial Stromal Sarcoma, and Bladder Reconstruction.

Dr. O'Shaughnessy is a Medical Oncologist that focuses on breast cancer prevention and treatment. She founded The School of Breast Oncology, a program providing a curriculum-based program focused exclusively on breast cancer clinical management. Dr. O'Shaughnessy attended medical school at Yale University School of Medicine in New Haven, CT. She then completed her Internal Medicine residency at Massachusetts General Hospital in Boston, MA and a Medical Oncology fellowship at National Cancer Institute in Bethesda, MD. She is co-chair of Breast Cancer Research, chair of Breast Cancer Prevention Research at Baylor Charles A. Sammons Cancer Center and a member of the Scientific Advisory Board for US Oncology Research Network. Dr. O'shaughnessy is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, PIK3CA-Related Overgrowth Spectrum, Inflammatory Breast Cancer, and Tissue Biopsy. Dr. O'shaughnessy is board certified in Medical Oncology- American Board Of Internal Med/Medical Oncology, Internal Medicine- American Board Of Internal Med, Internal Medicine- American Board Of Internal Medicine, and Medical Oncology- American Board Of Internal Medicine.

Dr. Max Kates is the R. Christian B. Evensen Professor and an associate professor of urology and oncology at the Brady Urological Institute at Johns Hopkins. He also directs the Division of Urologic Oncology for the Brady Urological Institute. Dr. Kates completed his undergraduate degree at Wesleyan University in Connecticut before pursuing his medical degree at Mount Sinai School of Medicine in New York. He then went on to train at Johns Hopkins for his urologic residency and Society of Urologic Oncology (SUO) fellowship. Dr. Kates has expertise in all areas of urologic oncology, with a particular emphasis on bladder and prostate cancer. With training in open, endoscopic, and robotic surgical approaches, Dr. Kates’ surgical philosophy is to assess the unique needs of each patient, and develop the right treatment plan for their malignancy. He is very hands on in his approach in the clinic and the operating room, and believes open communication with the patient, the patient’s family, and referring providers is key to ensuring a speedy recovery. As the clinical director of the bladder cancer multidisciplinary clinic, Dr. Kates works with the team at the Johns Hopkins Greenberg Bladder Cancer Institute to deliver a personalized approach to bladder cancer utilizing cutting edge precision medicine approaches. Dr. Kates’ research interests involve novel treatments for cancers of the urinary tract. Dr. Kates has authored more than 135 journal articles in the fields of bladder, prostate, and kidney cancer. He currently has a provisional patent for a novel intravesical chemotherapy developed with nano-engineer collaborators. Additionally, Dr. Kates has made important discoveries into the mechanism of action of intravesical BCG, the most common treatment for bladder cancer. He is the principal investigator on multiple trials, and is currently leading EA8212 BRIDGE, which is a randomized trial open in over 150 centers in the United States comparing BCG to GemDoce chemotherapy for early stage bladder cancer. To inquire about an appointment or make a referral, Dr. Kates can be contacted by phone (410) 614-0009. Dr. Kates is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy. Dr. Kates is board certified in American Board Of Urology.

Dr. Partridge received her MD from Cornell University Medical College in 1995. She completed her residency in internal medicine at the Hospital of the University of Pennsylvania and went on to complete fellowships in medical oncology and hematology at DFCI, MGH and BWH. She also received an MPH from Harvard School of Public Health. She is a medical oncologist who cares for adults with breast cancer, with a particular focus on the unique needs of young patients with breast cancer. She also leads efforts to optimize cancer survivorship care and research at DFCI. She completed fellowships in Medical Oncology and Hematology at DFCI, Massachusetts General Hospital and Brigham and Women’s Hospital. Dr. Partridge is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, BRCA Positive Breast Cancer, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy. Dr. Partridge is board certified in Medical Oncology.

I realized during a biology class in college that I could use my interest in science to help make a difference in people’s lives. It drove my decision to pursue a career in medicine. I realized early in medical school that I wanted to spend my career trying to understand cancer, how to fight it and caring for patients who have it. As a medical oncologist with Duke Cancer Center, I specialize in cancers of the chest, including lung cancer and mesothelioma. Working closely with my patients, getting to know them personally and understanding their values and goals, allows me to develop individualized care and treatment plans for each one. The most rewarding part of my work is developing long term relationships with my patients and their families throughout their cancer journeys. I am motivated and inspired by how my patients live their lives everyday. Dr. Melson is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC). Dr. Melson is board certified in American Board Of Internal Med, Medical Oncology.

Brendan Curti is an Oncologist practicing medicine in Portland, Oregon. Dr. Curti is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Melanoma, Renal Cell Carcinoma (RCC), Prostate Cancer, and Metastatic Uveal Melanoma.

Robert P. Edwards, MD, is the Chair of Ob/Gyn/RS at  UPMC Magee-Womens Hospital. Dr. Edwards is co-leader of the UPMC Gynecologic Cancer Program, and a professor of medicine in the Department of Obstetrics, Gynecology, and Reproductive Sciences at the University of Pittsburgh School of Medicine.Dr. Edwards specializes in all aspects of gynecologic oncology, and has a particular interest in intraperitoneal chemotherapy. and immunotherapty.Dr. Edwards is board-certified in obstetrics and gynecology, as well as gynecologic oncology. He received an undergraduate degree at Gettysburg College in Gettysburg, Pa., and received a medical degree at the University of Pittsburgh School of Medicine. Dr. Edwards completed a residency in obstetrics and gynecology at Magee-Womens Hospital of UPMC, and a fellowship in gynecologic oncology at the University of Alabama at Birmingham.Dr. Edwards is a member of professional organizations including the University of Pittsburgh Physicians Board of Directors, American Medical Association, American College of Surgeons, American College of Obstetricians and Gynecologists, American Association for Cancer Research, American Society of Clinical Oncology, Society of Gynecologic Oncologists, American Society of Colposcopy and Cervical Pathology, International Society for Biological Therapy of Cancer, American Association for the Advancement of Science, and the International Gynecologic Cancer Society. Dr. Edwards is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Vaginal Cancer, Hysterectomy, and Vulvectomy. Dr. Edwards is board certified in American Board Of Obstetrics And Gynecology and American Board Of Obstetrics And Gynecology. Dr. Edwards is currently accepting new patients.